Co-chairs for the 2008 forum are:
Dr Vose is the Neumann M. and Mildred E. Harris Professorial Chair and is the current Chief of the Oncology/Hematology Section in the Department of Internal Medicine at UNMC. Dr Vose received all of her medical education and training at UNMC and has been on faculty since 1990. Dr Vose is an internationally known leading expert in the treatment of patients with lymphoma. Dr Vose has served in many national and international review panels and is actively involved in various administrative positions in various local and national organizations. Dr Vose is actively involved in various novel clinical trials and is a member of the Nebraska Lymphoma Study Group. Dr Vose is the current co-program leader of the Hematologic Malignancy Program at the UNMC Eppley Cancer Center. Dr Vose has published over 220 articles in various medical journals, most of which deals with finding optimum care and treatment for patients with lymphoma. She has served on the editorial boards of various hematology and oncology journals, and serves as an expert reviewer as well.
Medical Oncologist at the BC Cancer Agency, Clinical Associate Professor at the University of British Columbia
Dr Laurie Sehn has been a Clinical Assistant Professor with the BC Cancer Agency and University of British Columbia, Canada, where she is a Medical Oncologist and Clinical Investigator with the lymphoma tumour group, since 1998. Dr Sehn graduated from McGill Medical School, Montreal, Canada, in 1991 and received her training in internal medicine at Columbia Presbyterian Medical Center, Columbia University, New York, USA. She was trained in haematology-oncology at the Dana Farber Cancer Institute and Brigham and Women’s Hospital, Harvard University, Boston, and received a Masters of Public Health degree from Harvard School of Public Health, Harvard University in 1997. Prior to returning to Canada, she spent a year at the Dana Farber Cancer Institute as a Bone Marrow Transplant specialist. Dr. Sehn has served on the Board of Directors of the Lymphoma Foundation Canada (LFC) since 2002, and is currently the Director of Research Fellowships for the LFC. Dr Sehn's research interests include all of the lymphoid cancers with particular interest in the biology and treatment of large cell lymphoma, the application of new imaging techniques such as PET scanning to lymphoma management and innovative new approaches to treatment. She is the lead investigator of a major new clinical trial focusing on the use of PET scanning in the therapy of large cell lymphoma.
